What is Found?
Found is a telehealth weight loss platform that pairs patients with board-certified providers — many specializing in obesity medicine — who prescribe GLP-1 medications and other weight management drugs. Founded in 2019, Found differentiates itself by offering a broader range of medications than most competitors and by emphasizing provider-patient relationships over quick-script efficiency.
In a market where many programs only prescribe one or two drugs, Found's multi-medication approach is its defining feature. Here is what that looks like in practice.
The intake process in detail
You start with an online health assessment covering medical history, weight loss goals, current medications, allergies, and insurance information. Found uses this information to match you with an appropriate provider — the matching algorithm considers your state, medical complexity, and medication preferences.
Within a few days, you get a video visit with a licensed clinician. Found's provider network includes physicians and nurse practitioners, many with obesity medicine board certification or equivalent training. The initial visit typically runs 20-30 minutes and covers your metabolic profile, medication options, lifestyle factors, and a treatment plan. Providers ask about previous weight loss attempts, your relationship with food, exercise habits, sleep quality, and mental health. This is more thorough than the asynchronous questionnaires used by platforms like Hims.
After the visit, your provider sends a prescription to Found's pharmacy partner network. Medication typically arrives within 5-10 days of your initial consultation. Faster than Calibrate, slower than Hims.
Medication options and how Found handles prescriptions
Found prescribes across several drug classes, which is its biggest differentiator:
GLP-1 agonists: Semaglutide (both compounded and brand-name), tirzepatide (both compounded and brand-name). Found can route brand-name prescriptions through insurance where coverage exists.
Combination therapies: Metformin (for insulin resistance), bupropion/naltrexone (Contrave, for food-noise reduction and cravings), topiramate (for appetite suppression, particularly in patients with migraine comorbidity).
Adjunct medications: Based on your individual metabolic profile. Some patients receive thyroid support, PCOS-related medications, or other targeted treatments.
This breadth matters. If a GLP-1 is not right for you — due to cost, contraindications, insurance barriers, or side effect intolerance — Found can pivot to alternatives without sending you to a different program. Many patients start on a non-GLP-1 medication and later transition to a GLP-1 when their situation changes (new insurance, cost reduction, supply improvement). Others use combination approaches — a GLP-1 plus metformin, for example — that require a provider comfortable managing multiple medications. Consult your prescriber about which combination, if any, is appropriate for your profile.
The Found app and daily experience
Found's app serves as the hub for your program. The daily experience includes weight logging, medication reminders, provider messaging, and behavior change content.
The behavior change layer includes daily lessons on nutrition, movement, sleep, and mindset. These are shorter and less structured than Calibrate's year-long curriculum — think 5-10 minute daily lessons rather than a formal education program. The content is evidence-based but lighter touch. Found also integrates a community feature where patients can share experiences and support each other.
Practically, most patients interact with the app for 5-10 minutes daily: log weight, read a lesson, check medication reminders. The provider messaging feature is useful between appointments — you can ask questions about side effects, dosing, or lifestyle adjustments without scheduling a full visit.
The app is functional without being exceptional. It gets the job done for tracking and communication. It is not as polished as Noom or as clinically detailed as Calibrate's app, but it covers the essentials.
Pricing tiers and what each includes
Found's pricing model has evolved. As of early 2026:
Essential tier (~$99/month): Provider consultations, basic coaching content, medication management, and program support. This tier covers the clinical relationship and prescription management.
Premium tier (~$149/month): Everything in Essential plus enhanced coaching access, more frequent provider check-ins, priority scheduling, and expanded behavior change content.
Medication costs: Billed separately. Compounded semaglutide typically runs $150-$250/month through Found's pharmacy partners. Brand-name GLP-1s are routed through insurance where covered. Other medications (metformin, Contrave) are generally much cheaper — often $20-$50/month.
Total self-pay cost: Expect $250-$400/month for membership plus a compounded GLP-1. Significantly less if you are on non-GLP-1 medications or have insurance covering brand-name drugs.
Coaching model
Found's coaching is lighter than Calibrate's but more substantive than Hims (which offers no coaching). You receive habit change programming through the app, monthly or bimonthly provider check-ins, and access to community support. The coaching is not 1:1 dedicated coaching in the Calibrate sense — it is more of a guided content experience with provider oversight.
For patients who want structured accountability, this may not be enough. For patients who are self-motivated and primarily want good clinical care with some behavioral support, Found's model hits a reasonable middle ground.
Insurance support
Found navigates insurance for brand-name GLP-1s and handles prior authorizations. This is a real service — prior authorization for weight loss medications is notoriously time-consuming, and Found's team manages it on your behalf.
If your insurance covers Wegovy or Zepbound, Found can route your prescription to achieve your copay rate. If insurance denies coverage, Found can pivot to compounded alternatives or non-GLP-1 medications. This flexibility is valuable — you are not stuck if insurance says no.
For compounded medications, Found works with multiple 503A pharmacy partners. Insurance does not cover compounded formulations, so those are always self-pay.
How Found compares
vs. Calibrate: Calibrate offers more structure, deeper coaching, and a year-long commitment. Found is more flexible, less expensive, and offers more medication options. Choose Calibrate if you want maximum accountability. Choose Found if you want clinical depth with more flexibility and lower cost.
vs. Noom Med: Noom Med has a stronger behavior change app but lighter clinical oversight. Found's providers are generally more experienced in obesity medicine. If behavior change content is your priority, Noom Med may be better. If clinical quality and medication flexibility matter more, Found has the edge.
vs. Hims: Hims is faster and cheaper for straightforward compounded semaglutide. Found offers more medications, better clinical depth, and insurance routing. Choose Hims for speed and simplicity. Choose Found for clinical substance.
Clinical oversight model
Found's clinical model sits between the quick-script platforms (Hims, Done) and the high-touch programs (Calibrate, Form Health). Provider quality is generally strong — Found emphasizes obesity medicine credentials, and the network includes physicians who treat weight management as a primary specialty, not a side offering.
Visits are substantive enough to discuss labs, comorbidities, and medication adjustments in detail. Found orders labs when clinically indicated and uses metabolic markers to guide treatment decisions beyond scale weight. Your provider can adjust medications, add combinations, or change approaches based on your response — something that single-drug platforms cannot do.
Strengths and weaknesses
Strengths: More medication options than almost any competitor. Strong provider quality with obesity medicine expertise. Insurance routing for brand-name GLP-1s. Reasonable pricing given the clinical depth. Flexibility to pivot medications if the first approach does not work.
Weaknesses: Coaching is secondary to clinical care — not as structured as Calibrate. Variable wait times for initial appointments in some states. Compounded medication consistency can vary between pharmacy partners (an industry-wide issue, not Found-specific). The app is functional but not best-in-class.
Who it is best for — and who should look elsewhere
Found is best for patients who want a provider with genuine obesity medicine expertise, may need medication options beyond just GLP-1s, have complex metabolic profiles (PCOS, insulin resistance, depression-related weight gain), want insurance navigation for brand-name drugs, or prefer a substantive provider relationship at a moderate price point.
Found is less ideal if you want the cheapest possible path to a GLP-1 prescription (Hims is cheaper), primarily want structured coaching and accountability (Calibrate is stronger), or want same-day prescriptions with minimal clinical gatekeeping.
Our bottom line
Found occupies a solid middle ground in the GLP-1 telehealth market. The multi-drug clinical model and provider quality give it an edge for patients with complex situations — multiple comorbidities, medication sensitivities, or previous treatment failures. The pricing is competitive without sacrificing clinical substance.
If your weight management needs are straightforward (healthy adult, want semaglutide, cost-sensitive), simpler platforms may suffice. But if you want a provider who can think across multiple drug classes and treat your metabolic profile holistically, Found delivers real value. Consult a prescriber to determine whether Found's multi-medication approach is appropriate for your situation.